AI-designed “intrabodies” could unlock new treatments for Alzheimer’s, Parkinson’s and MND
Researchers at the University of Essex have developed microscopic medicines that could pave the way for new approaches to treating neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and motor neurone disease (MND). Working with an international team, the scientists used artificial intelligence to create extremely small antibody fragments that can be…
